Persistent [tmco]
low [qlco]
urinary [qlco]
Excretion [phsf]
Marker [clna]
Favorable [qlco]
Survival [acty]
Follow-up [fndg]
Patients [podg]
Disseminated [spco]
Midgut [emst]
Carcinoid [neop]
tumours [neop]
Survival [acty]
Patients [podg]
Disseminated [spco]
Midgut [emst]
[M]Carcinoid tumours [neop]
Varies [inpr]
investigated [ftcn]
Factor [ftcn]
Survival [acty]
Referral [hlca]
Follow-up [fndg]
urinary levels [ftcn]
Hydroxyindoleacetic Acid [orch]
Patients [podg]
Study [mnob]
Urine [bdsu]
Collected [idcn]
H+ [elii]
Order [inpr]
Measure [qnco]
Levels [qlco]
Multivariate Analyses [qnco]
Performed [ftcn]
median [spco]
Follow-up [fndg]
months [tmco]
median [spco]
Survival [acty]
months [tmco]
Prognostic Factor [clna]
Poor [grpa]
Survival [acty]
High [qlco]
Age [orga]
High [qlco]
Gamma-glutamyl transferase level [lbpr]
Increased [qnco]
HIAA [orch]
Levels [qlco]
mmol/mol Creatinine [qnco]
Hazard Ratio [qnco]
Increased [qnco]
Level [qlco]
Confidence Interval [qnco]
P NOS [aapp, imft]
Multivariate Analysis [qnco]
Survival [acty]
Level [qlco]
Time [tmco]
Dependent [qlco]
Hazard Ratio [qnco]
Level [qlco]
Confidence Interval [qnco]
P NOS [aapp, imft]
Conclusion [idcn]
Patients [podg]
Persistent [tmco]
Moderately [qlco]
Increased [qnco]
urinary levels [ftcn]
Hydroxyindoleacetic Acid [orch]
mmol/mol Creatinine [qnco]
Favorable [qlco]
Outcome [ftcn]
[c] [qnco]
LTD [ortf]
Rights [qlco]
Reserve [acty]
